JOHNSON DOUGLAS G 4
4 · ALLOS THERAPEUTICS INC · Filed Jun 21, 2007
Insider Transaction Report
Form 4
JOHNSON DOUGLAS G
VP of Manufacturing
Transactions
- Exercise/Conversion
Common Stock
2007-06-19$2.42/sh+1,500$3,630→ 33,167 total - Sale
Common Stock
2007-06-19$6.63/sh−1,500$9,945→ 31,667 total - Exercise/Conversion
Stock Options (Right to buy)
2007-06-19$2.42/sh−1,500$3,630→ 25,260 totalExercise: $2.42From: 2001-01-12Exp: 2010-01-12→ Common Stock (1,500 underlying)
Footnotes (1)
- [F1]These shares are being sold pursuant to the 10b5-1 plan for Douglas G. Johnson dated February 9, 2007